Controversial Bee Venom Treatment for Lyme Disease Sparks Debate

A woman who experienced 15 years of post-treatment Lyme disease syndrome (PTLDS) symptoms found relief through a self-administered bee venom therapy. Ellie Lobel had dealt with fatigue and pain for years until a swarm of bees attacked her in March 2015. Despite being allergic to bees and suffering anaphylactic shock, she reported feeling significantly better a few days later.

Lobel began self-stinging regularly, which seemingly resolved her chronic Lyme symptoms. She has since advocated for bee sting therapy as an option when conventional antibiotic treatments prove insufficient.

However, the use of bee venom for Lyme disease is controversial and costly, with limited scientific validation for this specific application. While bee venom is FDA-approved for certain immunotherapies, it lacks approval from medical agencies for treating Lyme disease.

Meanwhile, tick-borne illnesses like Lyme disease are on the rise globally, partly due to expanding tick populations influenced by climate change. This increases the demand for alternative treatments but also highlights the critical need for scientifically validated methods to ensure patient safety and efficacy.